← board
TKNO
distress 2/10 · well-funded / low risk$5.240%today-18% from 52w high
Revenue
$11M
Liquidity
$18M
Runway
2.3 yrs
Shares 1y
+0%
Price & events
+57.4% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
-1.5%
1W
+7.2%
1M
+72.9%
3M
+57.8%
6M
+2.7%
1Y
+108.8%
2Y
-70.7%
5Y
-79.0%
All
Overview
- Market Cap
- $280.94M
- Enterprise Value
- $289.80M
- Volume
- 19.89K
- 52 Week Range
- $1.99 – $6.37
- Total Shares
- 53.61M
- Float Shares
- 10.88M
- Short %
- 11.47%
- % Held by Insiders
- 9.32%
- % Held by Institutions
- 84.73%
- RVOL
- 0.10x
- Beta
- 0.63
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-08-05Estimated 45%earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- 2024-07-10Stephens & Co.Overweight
Competitors
- none identified
Recent news
- 2026-07-22Teknova to report Q2FY26 results on August 5, 2026 - scanx.trade
- 2026-07-22Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026 - The Manila Times
- 2026-07-22Hear Teknova's Q2 results in an Aug. 5 webcast - Stock Titan
- 2026-07-17Form 4 Alpha Teknova Inc For: 16 July By Investing.com - Investing.com Nigeria
- 2026-07-16Alpha Teknova (TKNO) director shifts 12,000 common shares to trust - Stock Titan
- 2026-07-15How Alpha Teknova Inc. (TKNO) Affects Rotational Strategy Timing - Stock Traders Daily
- 2026-06-28Price to sales forward of Alpha Teknova, Inc. – NASDAQ:TKNO - TradingView
- 2026-06-26TKNO Stock Price and Chart — NASDAQ:TKNO - TradingView
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.